Aveni Foundation Press Releases

• Published on September 24, 2024 - 23:01 GMT

  

  DELTAREX-G FOR CAR-T CELL THERAPY INDUCED CYTOKINE RELEASE SYNDROME

  AUTHORS PUBLISH ON THE USE OF DELTAREX-G IN CAR-T CELL THERAPY INDUCED CYTOKINE RELEASE SYNDROME (Front. Mol. Med. 4: doi: 10.3389/fmmed.2024.1461151) LOS ANGELES, CA, UNITED STATES, September 24, 2024 /⁨EINPresswire.com⁩/ -- The Aveni Foundation and …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on April 15, 2024 - 13:00 GMT

  

  DELTAREX-G TUMOR AGNOSTIC THERAPY SHOWS CLINICAL BENEFIT IN CHEMORESISTANT STAGE 4 SARCOMA, PANCREATIC AND BREAST CANCER

  AUTHORS REPORT ENHANCED CCNG1 EXPRESSION IN 137 SARCOMA, PANCREAS AND BREAST CANCER TUMORS (https://doi.org/10.1158/1538-7445.AM2024-5183) LOS ANGELES, CALIFORNIA, USA, April 15, 2024 /⁨EINPresswire.com⁩/ -- The Aveni Foundation and the Sarcoma Oncology …

  Distribution channels: Banking, Finance & Investment Industry, Companies ...
• Published on December 11, 2023 - 14:00 GMT

  

  AVENI FOUNDATION PUBLISHES "FROM MENDEL TO GENE THERAPY" MAPPING THE HISTORY OF GENETIC MEDICINE

  DELTAREX-G IS THE FIRST TUMOR TARGETED GENE VECTOR TO GAIN ACCELERATED APPROVAL IN 2007. SANTA MONICA, CALIFORNIA, UNITED STATES OF AMERICA, December 11, 2023 /⁨EINPresswire.com⁩/ -- The Aveni Foundation and the Cancer Center of Southern California …

  Distribution channels: Banking, Finance & Investment Industry, Education ...
• Published on October 24, 2023 - 21:11 GMT

  

  AI ANALYSIS SHOWS ENHANCED CCNG1 EXPRESSION IN SARCOMA: A NOVEL BIOMARKER FOR DELTAREX-G CCNG1 INHIBITOR THERAPY

  PRESENTED BY DR. SANT P. CHAWLA AT THE EUROPEAN SOCIETY OF MEDICAL ONCOLOGY LOS ANGELES, CALIFORNIA, UNITED STATES OF AMERICA, October 24, 2023 /⁨EINPresswire.com⁩/ -- The Aveni Foundation and the Sarcoma Oncology Research Center, Santa Monica CA, are …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on August 3, 2023 - 13:00 GMT

  

  DELTAREX-G EXPANDS USFDA AUTHORIZED ACCESS TO BREAST CANCER, PANCREAS CANCER, OSTEOSARCOMA & SOFT TISSUE SARCOMA

  USFDA authorizes DeltaRex-G to be used as platform therapy upon which FDA approved cancer drugs may be added for better cancer control (NCT#04091295). LOS ANGELES, CALIFORNIA, UNITED STATES OF AMERICA, August 3, 2023 /⁨EINPresswire.com⁩/ -- The Aveni …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on July 17, 2023 - 07:02 GMT

  

  UK PHILANTHROPISTS SIMONE AND PAUL COMMINS DONATED GBP 1oo,ooo FOR DELTAREX-G CANCER RESEARCH

  Working towards a cure for advanced sarcoma LOS ANGELES, CA, USA, July 17, 2023 /⁨EINPresswire.com⁩/ -- Who: Simone and Paul Commins, a UK businessman who has curated a successful trading career, donated GBP 100,000 to Aveni Foundation for DeltaRex-G …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on July 7, 2023 - 07:27 GMT

  

  GUSTAVO SANTAOLALLA, TWO-TIME OSCAR WINNING FILM COMPOSER, PERFORMS A UNIQUE SOLO PRESENTATION FOR AVENI FOUNDATION

  SAVE THE DATE: SEPTEMBER 30, 2023 FOR THIS EXCITING EVENT IN BEVERLY HILLS, CALIFORNIA LOS ANGELES, CALIFORNIA, UNITED STATES, July 7, 2023 /⁨EINPresswire.com⁩/ -- Who: Two-Time Oscar Winning multi-instrumentalist, songwriter, producer and composer, …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Movie Industry ...
• Published on May 18, 2022 - 13:00 GMT

  

  DELTAREX-G AS FRONT-LINE TREATMENT FOR EARLY-STAGE BREAST CANCER SHOWS HEARTENING RESULTS

  First woman to receive DeltaRex-G as front-line treatment has no evidence of cancer recurrence. SANTA MONICA, CA, UNITED STATES, May 18, 2022 /⁨EINPresswire.com⁩/ -- Contact: Dr. Erlinda Maria Gordon, 818-726-3278, egordon@sarcomaoncology.com Who: A 75 …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Insurance Industry ...
• Published on September 22, 2021 - 07:11 GMT

  

  Little Boy Fighting Cancer Desperately needs Experimental Treatment as a Last Hope

  Youngest Patient to Receive DeltaRex-G, an Innovative Gene Targeted Cancer Therapy SANTA MONICA, CA, UNITED STATES, September 22, 2021 /⁨EINPresswire.com⁩/ -- Who: 11 year old Kian is fighting a rare cancer. This brave boy moved to Southern California …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on June 28, 2021 - 06:43 GMT

  

  DELTAREX-G GAINS FDA AUTHORIZATION AS ADJUVANT THERAPY FOR EARLY-STAGE TRIPLE NEGATIVE METAPLASTIC BREAST CANCER

  PREVENTING RECURRENCE OF TRIPLE NEGATIVE BREAST CANCER WITH TUMOR-TARGETED GENE THERAPY LOS ANGELES, CALIFORNIA, UNITED STATES, June 27, 2021 /⁨EINPresswire.com⁩/ -- The Aveni Foundation (www.avenifoundation.org), and the Cancer Center of Southern …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on January 4, 2021 - 14:00 GMT

  

  DELTAREX-G GAINS FDA AUTHORIZATION AS FIRST-LINE THERAPY FOR EARLY-STAGE TRIPLE RECEPTOR POSITIVE BREAST CANCER

  PREVENTING RECURRENCE WITH TUMOR-TARGETED GENE THERAPY: A LITMUS TEST LOS ANGELES, CA, UNITED STATES, January 4, 2021 /⁨EINPresswire.com⁩/ -- The Aveni Foundation (www.avenifoundation.org), and the Cancer Center of Southern California (www. …

  Distribution channels: Amusement, Gaming & Casino, Banking, Finance & Investment Industry ...
• Published on December 21, 2020 - 18:42 GMT

  

  DELTAREX-G GAINS EMERGENCY USE AUTHORIZATION FOR SEVERE COVID-19

  A TARGETED GENE THERAPY FOR COVID-19 INDUCED ARDS LOS ANGELES, CA, USA, December 21, 2020 /⁨EINPresswire.com⁩/ -- The Aveni Foundation (www.avenifoundation.org), in collaboration with Larkin Community Hospital, South Miami FL, Drs. Ellie Soheili and …

  Distribution channels: Aviation & Aerospace Industry, Banking, Finance & Investment Industry ...
• Published on November 11, 2020 - 14:00 GMT

  

  TUMOR MARKERS FOR DELTAREX-G GENE THERAPY, THE SAFER CHECKPOINT INHIBITOR FOR SARCOMA

  A BEACON IN OUR CAMPAIGN AGAINST SARCOMA LOS ANGELES, CA, UNITED STATES, November 11, 2020 /⁨EINPresswire.com⁩/ -- The Aveni Foundation and the Sarcoma Oncology Center / Cancer Center of Southern California, Santa Monica, CA, USA, are proud to announce …

  Distribution channels: Aviation & Aerospace Industry, Banking, Finance & Investment Industry ...
• Published on October 27, 2020 - 13:00 GMT

  

  CORONA STUDY USING DELTAREX-G FOR COVID-19

  Available now: “Right to Try” DeltaRex-G for COVID-19 EMERGENCY USE LOS ANGELES, CA, UNITED STATES, October 27, 2020 /⁨EINPresswire.com⁩/ -- The Aveni Foundation is proud to announce its new mission to treat COVID-19 induced pneumonia/Acute Respiratory …

  Distribution channels: Banking, Finance & Investment Industry, Conferences & Trade Fairs ...
• Published on October 26, 2020 - 17:00 GMT

  

  DELTAREX-G IMPEDES TUMOR GROWTH IN STAGE 4 CHEMOTHERAPY RESISTANT BONE CANCER

  Made possible by the Right to Try law of 2018 and the revival of a “tumor-targeted gene therapy” LOS ANGELES, CA, UNITED STATES, October 26, 2020 /⁨EINPresswire.com⁩/ -- The Aveni Foundation and the Cancer Center of Southern California are proud to …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on April 27, 2020 - 05:26 GMT

  

  DeltaRex-G Tumor-targeted Gene Therapy for Chemotherapy- Induced Leukemia

  Harvard and Mayo Clinic Investigators report a new clinical indication for DeltaRex-G genetic medicine. LOS ANGELES, CALIFORNIA, USA, April 26, 2020 /⁨EINPresswire.com⁩/ -- The Aveni Foundation is proud to announce the publication of a novel treatment for …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on August 19, 2019 - 07:07 GMT

  USFDA GRANTS EXPANDED ACCESS FOR DELTAREX-G, A PRECISION TUMOR TARGETED GENETIC MEDICINE FOR METASTATIC CANCER(S)

  “Expanded Access for DeltaRex-G and Right to Try law will give individuals with different types of cancer a chance to benefit from this innovative treatment." SANTA MONICA, CA, UNITED STATES, August 19, 2019 /⁨EINPresswire.com⁩/ -- The Aveni …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on March 12, 2019 - 06:12 GMT

  

  DeltaRex-G induces 10-year remission in a Stage IV pancreatic cancer patient: A cure for pancreatic cancer in 2019?

  DeltaRex-G: A cure for pancreatic cancer in 2019? SANTA MONICA, CA, UNITED STATES, March 11, 2019 /⁨EINPresswire.com⁩/ -- The Aveni Foundation and the Cancer Center of Southern California, Santa Monica CA proudly announce the promising results of a Phase …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...